For citations:
Feldblium I.V., Romanenko V.V., Subbotina K.A., Menshikova M.G., Okuneva I.A., Musikhina A.Y., Snitkovskaya T.E., Marcovich N.I., Ershov A.E., Trofimov D.M. Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial). Epidemiology and Vaccinal Prevention. 2021;20(1):32-43. (In Russ.) https://doi.org/10.31631/2073-3046-2021-20-1-32-43
Email this article 